
1 
This Order, which may be cited as the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Amendment Order 1987, amends the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Order 1983 (hereinafter referred to as “the principal Order”) and shall come into force on 30th April 1987.
2 

(1) In article 1(2) of the principal Order (interpretation) for the definition of “the Misuse of Drugs Regulations” there is substituted the following definition:“
 “the Misuse of Drugs Regulations” means, in relation to England, Wales and Scotland, the Misuse of Drugs Regulations 1985 and, in relation to Northern Ireland, the Misuse of Drugs (Northern Ireland) Regulations 1986;”.
(2) In article 6(2)(d), (4)(c) and (5) of the principal Order (which refers to emergency sale or supply by a retail pharmacist) and in article 12(2)(b) of the principal Order (conditions relating to prescriptions), for the words, “Schedule 2, 3 or 4 to the Misuse of Drugs Regulations” there are substituted the words, “Schedule 1, 2 or 3 to the Misuse of Drugs Regulations”.
3 

(1) In article 3(1)(a) of the principal Order (medicinal products on prescription only), after the words “subject to article 4(1)” there are inserted the words “and (1A), and Part IV of Schedule 1”.
(2) In article 4 of the principal Order (medicinal products that are not prescription only), after paragraph (1) there is inserted the following paragraph—“
(1A) Notwithstanding article 3(1)(a), medicinal products specified in Part IV of Schedule 1 shall not be prescription only medicines.”
(3) In Part I of Schedule 1 to the principal Order (which lists substances which render a medicinal product a prescription only medicine except in circumstances also listed)—
(a) there are inserted in column 1, at the appropriate point in the alphabetical order of the substances listed, the substances specified in column 1 of Schedule 1 to this Order and in columns 2 and 3, so as to appear against the particular substance to which it relates, there is inserted as the case may be any entry appearing in columns 2 and 3 of Schedule 1 to this Order against that substance;
(b) there are deleted from column 1 the substances specified in Schedule 2 to this Order;
(c) for the entry in columns 2 and 3 relating to the substance Podophyllum Resin listed in column 1 there is substituted the entry relating to that substance set out in columns 2 and 3 of Schedule 3 to this Order;
(d) 
(i) in the footnote to the column 4 entries relating to the substances Atropine, Atropine Methobromide, Atropine Methonitrate, Atropine Oxide Hydrochloride, Atropine Sulphate, Hyoscine Butylbromide, Hyoscine Hydrobromide, Hyoscine Methobromide, Hyoscine Methonitrate, Hyoscyamine, Hyoscyamine Hydrobromide and Hyoscyamine Sulphate, after the words, “Subject to” there are inserted the words, “paragraph 1 of”; and
(ii) in column 2 opposite each of the substances Sodium Fluoride, Sodium Monofluorophosphate and Stannous Fluoride there is inserted “(b)” and at the foot of each page where such an insertion is made there are inserted the words, “(b) Subject to paragraph 2 of the note at the end of Part I of Schedule 1.”; and
(iii) after the word “Note:” where it appears at the end of that Part there is inserted the number “1.” and after the entry for the Note numbered 1. there is inserted the following new paragraph:“
2 
In relation to a medicinal product which contains more than one of the substances Sodium Fluoride, Sodium Monofluorophosphate and Stannous Fluoride combined in a dentifrice, the maximum strength of the combination for the purposes of column 2 shall not exceed 0.15 per cent calculated as Fluorine.”
(4) In Part III of Schedule 1 to the principal Order (medicinal products, specified by name and product licence number, which are prescription only medicines) there is deleted the entry “Debrisan 0009/0021”.
(5) After Part III of Schedule 1 to the principal Order there is added Part IV as set out in Schedule 4 to this Order.
4 
From Schedule 2 to the principal Order (substances not to be contained in a prescription only medicine sold or supplied under the exemption conferred by article 6(3) of the principal Order), there are deleted the substances Phentermine Hydrochloride and Phentermine Resin Complex.
Signed by authority of the Secretary of State for Social Services.
Tony Newton
Minister of State,
Department of Health and Social Security
1st April 1987Nicholas Edwards
Secretary of State for Wales
31st March 1987Malcolm Rifkind
Secretary of State for Scotland
31st March 1987In witness whereof the official seal of the Minister of Agriculture, Fisheries and Food is hereunto affixed on 1st April 1987.
Michael Jopling
Minister of Agriculture, Fisheries and Food
Sealed with the official seal of the Department of Health and Social Services for Northern Ireland this 3rd day of April 1987.
Maurice N. Hayes
Permanent Secretary
Sealed with the official seal of the Department of Agriculture for Northern Ireland this 6th day of April 1987.
W. H. Jack
Permanent Secretary

SCHEDULE 1
Article 3(3)(a)


 CIRCUMSTANCES EXCLUDING MEDICINAL PRODUCTS FROM THE CLASS OF PRESCRIPTION ONLY MEDICINES
Column 1 Column 2 Column 3 Column 4
Substance Maximum strength Use, pharmaceutical form or route of administration Maximum dose and maximum daily dose
Amsacrine
Betamethasone Dipropionate
Bromperidol
Ceftazidime
Ceftizoxime Sodium
Dipivefrin Hydrochloride
Enalapril Maleate
Epirubicin
Fluvoxamine Maleate
Gemfibrozil
Iohexol
Lachesine Chloride
Lithium Citrate
Lofepramine Hydrochloride
Meglumine Ioxaglate
Metronidazole Benzoate
Minoxidil
Mitozantrone Hydrochloride
Nicergoline
Plicamycin
Saralasin Acetate
Sulconazole Nitrate  External (except vaginal use)
Suprofen
Tetroxoprim
Tioconazole 2.0 per cent External (except vaginal use)
Tobramycin
Vecuronium Bromide
SCHEDULE 2
Article 3(3)(b)


 Alprazolam
 Bromazepam
 Chlordiazepoxide
 Clobazam
 Clonazepam
 Dextropropoxyphene Hydrochloride
 Dextropropoxyphene Napsylate
 Diazepam
 Ethchlorvynol
 Flunitrazepam
 Flurazepam Hydrochloride
 Flurazepam Monohydrochloride
 Glutethimide
 Ketazolam
 Loprazolam Mesylate
 Lorazepam
 Lormetazepam
 Mazindol
 Medazepam
 Meprobamate
 Methyprylone
 Mithramycin
 Nitrazepam
 Oxazepam
 Pentazocine Hydrochloride
 Pentazocine Lactate
 Phentermine Hydrochloride
 Phentermine Resin Complex
 Prazepam
 Sutoprofen
 Temazepam
 Triazolam

SCHEDULE 3
Article 3(3)(c)


  CIRCUMSTANCES EXCLUDING MEDICINAL PRODUCTS FROM THE CLASS OF PRESCRIPTION ONLY MEDICINES
Column 1 Column 2 Column 3 Column 4
Substance Maximum strength Use, pharmaceutical form or route of administration Maximum dose and maximum daily dose
Podophyllum Resin 2.0 per cent External: ointment or impregnated plaster
SCHEDULE 4
Article 3(5)
“
PART IV

 Anflam Cream 0142/0190
 Anflam Ointment 0142/0191
 Beechams Hydrocortisone Cream 0079/0203
 Cortaid Cream 1% 0032/0126
 Cortaid Ointment 1% 0032/0127
 Corteze Cream 0001/0107
 Cortiderm 2855/0010
 Cortovate Hydrocortisone Cream 1% 0039/0198
 Cortril Topical Ointment 1% (non-greasy) 0057/0251
 CP Hydrocortisone Cream 0.5% 4543/0238
 CP Hydrocortisone Cream 1% 4543/0239
 CP Hydrocortisone Ointment 0.5% 4543/0236
 CP Hydrocortisone Ointment 1% 4543/0237
 Dermacort Hydrocortisone Cream 0129/0076
 Efcortelan P Cream 1% 0004/0327
 Efcortelan P Ointment 1% 0004/0326
 Femafen 0188/0071
 Hc45 Hydrocortisone Cream 0327/0039
 Kerfoot Hydrocortisone Cream 1% 0058/0092
 Lanacort Cream 3157/0008
 Lanacort Ointment 3157/0011
 Medicort Cream 3920/0010
 Oriel Capsules 0073/0023
 Pharmacort Cream 0.5% 0011/0077
 Proflex Sustained Relief Capsules 0001/0109
 Suspren 0188/0072
 Timocort Hydrocortisone Cream 0044/0090
 Wasp-Eze Hydrocortisone Cream 0232/0058
 Wasp-Eze Hydrocortisone Ointment 0232/0059
 Zenoxone Cream 0181/0033
 Zenoxone Ointment 0181/0032
”